Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIGITALX LIMITED Proxy Solicitation & Information Statement 2024

Dec 29, 2024

64762_rns_2024-12-29_eba0934a-d1cb-4499-9450-b8aef0f7e9b5.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [140 x 26] intentionally omitted <==

Dear Shareholder,

Notice of General Meeting and Proxy Form

DigitalX Limited (the Company ) will be holding a general meeting of shareholders at 9.30am (Perth time) on 31 January 2025 ( Meeting ) at Level 14, QV1 Building, 250 St Georges Terrace, Perth, Western Australia.

In accordance with clause 26.1(c) of the Company’s Constitution, the Company gives notice that the Notice of Meeting can be viewed and downloaded from the website link: https://www.digitalx.com/investor-centre.

A copy of your personalised proxy form is enclosed for your convenience. Please complete and return the attached proxy form to the Company’s share registry, Automic Group, as instructed below.

Shareholders are encouraged to vote by lodging a proxy form.

Proxy forms can be lodged:

  • Online: https://investor.automic.com.au/#/loginsah

  • By mail: Automic, GPO Box 5193, Sydney NSW 2001

  • In-person: Automic, Level 5, 126 Phillip Street, Sydney NSW 2000

  • By email: [email protected]

  • By fax: +61 2 8583 3040

  • By mobile: Scan the QR Code on your Proxy Form and follow the prompts

Your proxy voting instruction must be received by 9.30am (Perth time) on 29 January 2025, being not less than 48 hours before the commencement of the Meeting. Any proxy voting instructions received after that time will not be valid for the Meeting.

The Notice of Meeting is important and should be read in its entirety. If you are in doubt as to the course of action you should follow, you should consult your financial adviser, lawyer, accountant or other professional adviser. If you have any difficulties obtaining a copy of the Notice of Meeting please contact the Company’s share registry, Automic Group Limited, on 1300 288 664.

Sincerely, Mark Licciardo Company Secretary DigitalX Limited

DigitalX Limited | 59 009 575 035 | Level 4, 66 Kings Park Road West Perth WA 6005 | www.digitalx.com

DIGITALX LIMITED ACN 009 575 035 NOTICE OF GENERAL MEETING

Notice is given that the Meeting will be held at:

TIME : 9.30am (Perth time)

DATE : 31 January 2025 PLACE : Level 14, QV1 Building 250 St Georges Terrace Perth, Western Australia

The business of the Meeting affects your shareholding and your vote is important.

This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 4.00pm (Sydney time) on 29 January 2025.

B U S I N ES S OF TH E M EE T I N G

AGENDA

1. RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF SHARES UNDER PLACEMENT – LISTING RULE 7.1

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 119,960,604 Shares to Unrelated Placement Participants on the terms and conditions set out in the Explanatory Statement.”

2. RESOLUTION 2 – RATIFICATION OF PRIOR ISSUE OF SHARES UNDER PLACEMENT – LISTING RULE 7.1A

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 86,640,403 Shares to Unrelated Placement Participants on the terms and conditions set out in the Explanatory Statement.”

3. RESOLUTION 3 – APPROVAL TO ISSUE SHARES TO A RELATED PARTY – MR PETER RUBINSTEIN

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 10,000,000 Shares to Mr Peter Rubinstein (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

4. RESOLUTION 4 – APPROVAL TO ISSUE SHARES TO A RELATED PARTY – MR GREG DOOLEY

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 1,000,000 Shares to Mr Greg Dooley (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

5. RESOLUTION 5 – APPROVAL TO ISSUE SHARES TO A RELATED PARTY – DAVIDE BOSIO

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 2,000,000 Shares to Mr Davide Bosio (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

6. RESOLUTION 6 – APPROVAL TO ISSUE SHARES TO PLUTUS CAPITAL

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue up to 6,382,979 Shares to Plutus Capital (or its nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

7. RESOLUTION 7 – APPROVAL TO ISSUE OPTIONS TO PLUTUS CAPITAL

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue up to 2,000,000 Options to Plutus Capital (or its nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

1

8. RESOLUTION 8 – APPROVAL TO ISSUE OPTIONS TO ANTANAS GUOGA

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue up to 25,000,000 Options to Antanas Guoga (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

9. RESOLUTION 9 – RATIFICATION OF PRIOR ISSUE OF OPTIONS TO MR DAVIDE BOSIO

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 10,000,000 Options to Mr Davide Bosio (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

10. RESOLUTION 10 – APPROVAL TO ISSUE OPTIONS TO A RELATED PARTY – MR TOBY HICKS

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 10,000,000 Options to Mr Toby Hicks (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

11. RESOLUTION 11 – APPROVAL TO ISSUE OPTIONS TO A RELATED PARTY – MR PETER RUBINSTEIN

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 10,000,000 Options to Mr Peter Rubinstein (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

12. RESOLUTION 12 – APPROVAL TO ISSUE OPTIONS TO A RELATED PARTY – MR GREG DOOLEY

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 10,000,000 Options to Mr Greg Dooley (or his nominee(s)) on the terms and conditions set out in the Explanatory Statement.”

2

Voting Prohibition Statements

Resolution 3 – Approval to
issue Shares to a Related
Party – Mr Peter Rubinstein
In accordance with section 224 of the Corporations Act, a vote on this Resolution
must not be cast (in any capacity) by or on behalf of a related party of the
Company to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 3 Excluded Party). However,
the above prohibition does not apply if the vote is cast by a person as proxy
appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 3 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed
as a proxy must not vote, on the basis of that appointment, on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
Provided the Chair is not a Resolution 3 Excluded Party, the above prohibition
does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.
Resolution 4 – Approval to
issue Shares to a Related
Party – Mr Greg Dooley
In accordance with section 224 of the Corporations Act, a vote on this Resolution
must not be cast (in any capacity) by or on behalf of a related party of the
Company to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 4 Excluded Party). However,
the above prohibition does not apply if the vote is cast by a person as proxy
appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 4 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed
as a proxy must not vote, on the basis of that appointment, on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
Provided the Chair is not a Resolution 4 Excluded Party, the above prohibition
does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.
Resolution 5 – Approval to
issue Shares to a Related
Party – Mr Davide Bosio
In accordance with section 224 of the Corporations Act, a vote on this Resolution
must not be cast (in any capacity) by or on behalf of a related party of the
Company to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 5 Excluded Party). However,
the above prohibition does not apply if the vote is cast by a person as proxy
appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 5 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed
as a proxy must not vote, on the basis of that appointment, on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
Provided the Chair is not a Resolution 5 Excluded Party, the above prohibition
does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.

3

Resolution 10 – Approval to
issue Options to a Related
Party – Mr Toby Hicks
In accordance with section 224 of the Corporations Act, a vote on this Resolution
must not be cast (in any capacity) by or on behalf of a related party of the
Company to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 10 Excluded Party). However,
the above prohibition does not apply if the vote is cast by a person as proxy
appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 10 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed
as a proxy must not vote, on the basis of that appointment, on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
Provided the Chair is not a Resolution 10 Excluded Party, the above prohibition
does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.
Resolution 11 – Approval to
issue Options to a Related
Party – Mr Peter Rubinstein
In accordance with section 224 of the Corporations Act, a vote on this Resolution
must not be cast (in any capacity) by or on behalf of a related party of the
Company to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 11 Excluded Party). However,
the above prohibition does not apply if the vote is cast by a person as proxy
appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 11 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed
as a proxy must not vote, on the basis of that appointment, on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
Provided the Chair is not a Resolution 11 Excluded Party, the above prohibition
does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.
Resolution 12 – Approval to
issue Options to a Related
Party – Mr Greg Dooley
In accordance with section 224 of the Corporations Act, a vote on this Resolution
must not be cast (in any capacity) by or on behalf of a related party of the
Company to whom the Resolution would permit a financial benefit to be given,
or an associate of such a related party (Resolution 12 Excluded Party). However,
the above prohibition does not apply if the vote is cast by a person as proxy
appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 12 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed
as a proxy must not vote, on the basis of that appointment, on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
Provided the Chair is not a Resolution 12 Excluded Party, the above prohibition
does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.

4

Voting Exclusion Statements

In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the Resolution set out below by or on behalf of the following persons:

Resolution 1 – Ratification of
prior issue of Shares under
Placement– Listing Rule 7.1
Placement Participants or any other person who participated in the issue or an
associate of that person or those persons.
Resolution 2 – Ratification of
prior issue of Shares under
Placement– Listing Rule 7.1A
Placement Participants or any other person who participated in the issue or an
associate of that person or those persons.
Resolution 3 – Approval to
issue Shares to a Related Party
Mr Peter Rubinstein
Mr Peter Rubinstein (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of that person or those persons.
Resolution 4 – Approval to
issue Shares to a Related Party
Mr Greg Dooley
Mr Greg Dooley (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of that person or those persons.
Resolution 5 – Approval to
issue Shares to a Related Party
Mr Davide Bosio
Mr Davide Bosio (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of that person or those persons.
Resolution 6 – Approval to
issue Shares to Plutus Capital
Plutus Capital (or its nominee(s)) or any other person who is expected to
participate in, or who will obtain a material benefit as a result of, the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities
in the Company) or an associate of that person (or those persons).
Resolution 7 – Approval to
issue Options to Plutus Capital
Plutus Capital (or its nominee(s)) or any other person who is expected to
participate in, or who will obtain a material benefit as a result of, the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities
in the Company) or an associate of that person (or those persons).
Resolution 8 – Approval to
issue Options to Antanas
Guoga
Antanas Guoga (or his nominee(s)) or any other person who is expected to
participate in, or who will obtain a material benefit as a result of, the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities
in the Company) or an associate of that person (or those persons).
Resolution 9 – Ratification of
prior issue of Options to Davide
Bosio
Mr Davide Bosio (or their nominee(s)) or any other person who participated in
the issue or an associate of that person or those persons.
Resolution 10 – Approval to
issue Options to a Related
Party – Mr Toby Hicks
Mr Toby Hicks (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of that person or those persons.
Resolution 11 – Approval to
issue Options to a Related
Party – Mr Peter Rubinstein
Mr Peter Rubinstein (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of that person or those persons.
Resolution 12 – Approval to
issue Options to a Related
Party – Mr Greg Dooley
Mr Greg Dooley (or his nominee(s)) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit solely
by reason of being a holder of ordinary securities in the Company) or an
associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

5

Voting by proxy

To vote by proxy, please complete Proxy Form and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, Shareholders are advised that:

  • each Shareholder has a right to appoint a proxy;

  • the proxy need not be a Shareholder of the Company; and

  • a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints two proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

Shareholders and their proxies should be aware that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

Voting in person

To vote in person, attend the Meeting at the time, date and place set out above.

You may still attend the Meeting and vote in person even if you have appointed a proxy. If you have previously submitted a Proxy Form, your attendance will not revoke your proxy appointment unless you actually vote at the Meeting for which the proxy is proposed to be used, in which case, the proxy’s appointment is deemed to be revoked with respect to voting on that Resolution.

Please bring your personalised Proxy Form with you as it will help you to register your attendance at the Meeting. If you do not bring your Proxy Form with you, you can still attend the Meeting but representatives from Automic will need to verify your identity. You can register from 8:30am on the day of the Meeting.

Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company Secretary on +61 8 9388 3742.

6

E X PL A N A T O R Y S T A T EM E N T

This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions.

1. BACKGROUND TO RESOLUTIONS 1 TO 7

On 18 December 2024, the Company announced that it had completed a private placement to sophisticated and institutional investors to raise approximately $10.3 million at $0.047 per Share ( Placement ).

The Placement comprises:

  • (a) 206,601,007 Shares issued to sophisticated and institutional investors unrelated to the Company ( Unrelated Placement Participants ) on 30 December 2024, comprising:

  • (i) 119,960,604 Shares under the Company’s placement capacity under Listing Rule 7.1, which the Company is seeking to ratify under Resolution 1; and

(ii) 86,640,403 Shares Listing Rule 7.1A, which the Company is seeking to ratify under Resolution 2;

  • (b) 13,000,000 Shares which will be issued to Mr Peter Rubinstein, Mr Greg Dooley and Mr Davide Bosio ( Related Party Participants ), subject to obtaining Shareholder approval under Resolutions 3 to 5.

In addition to the Placement, the Company will issue 6,382,979 Shares and 2,000,000 Options to be issued to Plutus Capital pursuant to the Lead Manager Mandate (as defined below).

1.2 Lead Manager

On 15 December 2024, the Company entered into a mandate with Plutus Capital Advisory ( Plutus Capital ) pursuant to which Plutus Capital was engaged by the Company to act as lead manager to the Placement ( Lead Manager Mandate ).

  • (a) In accordance with the terms of the Lead Manager Mandate the Company has agreed to pay Plutus Capital (or its nominee(s)) the following fees (exclusive of GST):

  • (i) a placement fee of $300,000 (payable in shares in lieu of cash at the election of Plutus Capital); and

  • (ii) 2,000,000 options exercisable at $0.10 on or before the date that is 2 years from the date of issue.

  • (b) Upon successful completion of the Placement, Plutus will receive a first right of refusal for 12 months to act as the sole and exclusive lead manager for the Company’s next equity raising.

  • (c) Other than as noted above, the Lead Manager Mandate contains terms which are standard for an agreement of this type.

1.3 Use of funds

The funds raised from the Placement are intended to be used for growth and expansion of the Company’s digital asset activities and working capital.

2. RESOLUTIONS 1 AND 2 – RATIFICATION OF ISSUE OF PLACEMENT SHARES

2.1 General

This Resolution seeks Shareholder ratification for the purposes of Listing Rule 7.4 for the issue of Shares to the Unrelated Placement Participants.

7

2.2 Listing Rules 7.1 and 7.1A

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that 12 month period.

Under Listing Rule 7.1A however, an Eligible Entity can seek approval from its members, by way of a special resolution passed at its annual general meeting, to increase this 15% limit by an extra 10% to 25%. The Company obtained this approval at its annual general meeting held on 28 November 2024.

The issue does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has not yet been approved by Shareholders, it effectively uses up part of the 25% limit in Listing Rules 7.1 and 7.1A, reducing the Company’s capacity to issue further equity securities without Shareholder approval under Listing Rule 7.1 and 7.1A for the 12 month period following the date of the issue.

2.3 Listing Rule 7.4

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further equity securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional equity securities in the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to Listing Rule 7.4 for the issue.

2.4 Technical information required by Listing Rule 14.1A

If these Resolutions are passed, the issue will be excluded in calculating the Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of the issue.

If these Resolutions are not passed, the issue will be included in calculating the Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively decreasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of the issue.

2.5 Technical information required by Listing Rules 7.4 and 7.5 in respect of these Resolutions

REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities were issued or the
basis on which those
persons were
identified/selected
The Shares were issued to professional and sophisticated
investors who were identified through a bookbuild process,
which involved Plutus Capital seeking expressions of interest
to participate in the capital raising from non-related parties
of the Company.
Number and class of
Securities issued
119,960,604 Shares were issued pursuant to Listing Rule 7.1
and 86,640,403 Shares were issued pursuant to Listing Rule
7.1A.
Terms of Securities The Shares were fully paid ordinary shares in the capital of
the Company issued on the same terms and conditions as
the Company’s existing Shares.
Date(s) on or by which the
Securities were issued
30 December 2024.
Price or other consideration
the Company received for
the Securities
$0.047 per Share
Purpose of the issue,
including the intended use
Refer to Section 1.3 for details of the proposed use of funds.

8

REQUIRED INFORMATION DETAILS
of any funds raised by the
issue
Summary of material terms
of agreement to issue
The Shares were issued pursuant to customary placement
agreements between the Company and the Unrelated
Placement Participants.
Voting Exclusion Statement A voting exclusion statement applies to this Resolution.
Compliance The issue did not breach Listing Rule 7.1.

3. RESOLUTIONS 3 TO 5 – APPROVAL TO ISSUE SHARES TO RELATED PARTIES

3.1 General

To enable the Directors to participate in the Company’s Placement on the same terms as the Unrelated Placement Participants, Resolutions 3 to 5 seek Shareholder approval for the purposes of Listing Rule 10.11 for the issue of up to an aggregate of 13,000,000 Shares to the Related Party Participants (or their nominee(s)) on the terms and conditions set out below.

Further details in respect of the intended participation of the Related Party Participants are set out in the table below.

RECIPIENT RESOLUTION PARTICIPATION PARTICIPATION
QUANTUM SHARES FUNDS RAISED
Mr Peter Rubinstein 3 10,000,000 $470,000
Mr Greg Dooley 4 1,000,000 $47,000
Mr Davide Bosio 5 2,000,000 $94,000
Total 13,000,000 $611,000

3.2 Director Recommendation

Mr Toby Hicks recommends that Shareholders vote in favour of these Resolutions to enable the Directors to participate in the Placement on the same terms as Unrelated Placement Participants.

Each Director (other than Mr Toby Hicks) has a material personal interest in the outcome of these Resolutions on the basis that the Directors (other than Mr Toby Hicks (or their nominee(s)) are to be issued Shares should these Resolutions be passed. For this reason, the Directors (other than Mr Toby Hicks) do not believe that it is appropriate to make a recommendation on these Resolutions.

3.3 Listing Rule 10.11

Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue equity securities to:

  • 10.11.1 a related party;

  • 10.11.2 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (30%+) holder in the company;

  • 10.11.3 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (10%+) holder in the company and who has nominated a director to the board of the company pursuant to a relevant agreement which gives them a right or expectation to do so;

  • 10.11.4 an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3; or

  • 10.11.5 a person whose relationship with the company or a person referred to in Listing Rules 10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be approved by its shareholders,

9

unless it obtains the approval of its shareholders.

The issue falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.

3.4 Technical information required by Listing Rule 14.1A

If these Resolutions are passed, the Company will be able to proceed with the issue within one month after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules). As approval pursuant to Listing Rule 7.1 is not required for the issue (because approval is being obtained under Listing Rule 10.11), the issue will not use up any of the Company’s 15% annual placement capacity.

If these Resolutions are not passed, the Company will not be able to proceed with the issue. Accordingly, the Company will not raise a further $611,000 under the Placement.

3.5 Technical Information required by Listing Rule 10.13 and section 219 of the Corporations Act in respect of these Resolutions

REQUIRED INFORMATION DETAILS
Name of the persons to
whom Securities will be
issued
The Shares will be issued to Mr Peter Rubinstein, Mr Greg
Dooley and Davide Bosio (or their nominee(s)).
Categorisation under Listing
Rule 10.11
Each of the proposed recipients falls within the category set
out in Listing Rule 10.11.1 as they are each a related party of
the Company by virtue of being a Director.
Any nominee(s) of the proposed recipients who receive
Shares may constitute ‘associates’ for the purposes of Listing
Rule 10.11.4.
Number of Securities and
class to be issued
The maximum number of Shares to be issued is 13,000,000
Shares in the allocations set out in Section 3.1.
Terms of Securities The Shares will be fully paid ordinary shares in the capital of
the Company issued on the same terms and conditions as the
Company’s existing Shares.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Shares within 5 Business
Days of the Meeting. In any event, the Company will not issue
any Shares later than one month after the date of the
Meeting (or such later date to the extent permitted by any
ASX waiver or modification of the Listing Rules).
Price or other consideration
the Company will receive
for the Securities
$0.047 per Share
Purpose of the issue,
including the intended use
of any funds raised by the
issue
Refer to Section 1.3 for details of the proposed use of funds.
Consideration of type and
quantum of Security to be
issued
The recipients are seeking to participate in the Placement on
the same terms as the Unrelated Placement Participants.
It is not considered that there are any significant opportunity
costs to the Company or benefits foregone by the Company
in issuing the Shares on the terms proposed.

10

REQUIRED INFORMATION DETAILS DETAILS DETAILS DETAILS
Valuation The value of the Shares proposed to be issued is set out in the
table below, based on a valuation of $0.047 per Share.
RECIPIENT
SHARES
VALUE
Mr Peter Rubinstein
10,000,000
$470,000
Mr Greg Dooley
1,000,000
$47,000
Mr Davide Bosio
2,000,000
$94,000
RECIPIENT SHARES VALUE
Mr Peter Rubinstein 10,000,000 $470,000
Mr Greg Dooley 1,000,000 $47,000
Mr Davide Bosio 2,000,000 $94,000
Summary of material terms
of agreement to issue
The Shares were issued pursuant to customary placement
agreements between the Company and the Related Party
Participants.
Interest in Securities The relevant interests of the proposed recipients in Securities
as at the date of this Notice and following completion of the
issue are set out below:
As at the date of this Notice
RECIPIENT
SHARES1
OPTIONS
UNDILUTED
Mr Peter
Rubinstein
36,578,320
Nil
4.22%
Mr Greg
Dooley
1,773,601
Nil
0.20%
Mr Davide
Bosio
Nil
10,000,0002
Nil
Post issue
RECIPIENT
SHARES1
OPTIONS
Mr Peter Rubinstein
46,578,320
Nil
Mr Greg Dooley
2,773,601
Nil
Mr Davide Bosio
2,000,000
10,000,0002
Notes:
1
Fully paid ordinary shares in the capital of the Company (ASX:
DCC).
2
Uquoted Options exercisable at $0.10 each on or before 31
December 2029.
Dilution If the Shares issued under these Resolutions are exercised, a
total of 13,000,000 Shares would be issued. This will increase
the number of Shares on issue from 866,404,031 (being the
total number of Shares on issue as at the date of this Notice)
to 879,404,031 (assuming that no Shares are issued and no
other convertible securities vest or are exercised) with the
effect that the shareholding of existing Shareholders would be
diluted by an aggregate of 1.48%, comprising 1.14% by Mr
Rubinstein, 0.12% by Mr Dooley and 0.23% by Mr Bosio.
Trading history The trading history of the Shares on ASX in the 12 months
before the date of this Notice is set out below:
PRICE
DATE
Highest
$0.086
12 March 2024
Lowest
$0.035
4 October 2024
Last
$0.053
13 December 2024
PRICE DATE
Highest $0.086 12 March 2024
Lowest $0.035 4 October 2024
Last $0.053 13 December 2024

11

REQUIRED INFORMATION
Other information
Voting exclusion statements
Voting prohibition
statements
DETAILS
The Board is not aware of any other information that is
reasonably required by Shareholders to allow them to decide
whether it is in the best interests of the Company to pass these
Resolutions.
Voting exclusion statements apply to these Resolutions.
Voting prohibition statements apply to these Resolutions.

4. RESOLUTION 6 AND 7 – APPROVAL TO ISSUE OPTIONS AND SHARES TO PLUTUS CAPITAL

4.1 General

This Resolution seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of 6,382,979 Shares and 2,000,000 Options to Plutus Capital in consideration for its lead manager services provided under the Placement.

4.2 Listing Rule 7.1

A summary of Listing Rule 7.1 is set out in Section 2.2 above.

The proposed issue falls within exception 17 of Listing Rule 7.2. It therefore requires the approval of Shareholders under Listing Rule 7.1.

4.3 Technical information required by Listing Rule 14.1A

If these Resolutions are passed, the Company will be able to proceed with the issue. In addition, the issue will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If these Resolutions are not passed, the Company will not be able to proceed with the issue. Accordingly, the Company would have to pay its fees owing to Plutus Capital for its lead manager services in cash which would further deplete the Company’s existing cash reserves.

4.4 Technical information required by Listing Rule 7.3 in respect of Resolutions 6 and 7

REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities will be issued or the
basis on which those persons
were or will be
identified/selected
The Shares and Options will be issued to Plutus Capital (or
its nominee(s)).
Number of Securities and
class to be issued
6,382,979 Shares and 2,000,000 Options will be issued to
Plutus Capital (or its nominee(s)).
Terms of Securities The Shares will be fully paid ordinary shares in the capital of
the Company issued on the same terms and conditions as
the Company’s existing Shares.
The Options will be issued on the terms and conditions set
out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Shares and Options
within 5 Business Days of the Meeting. In any event, the
Company will not issue any of the Shares or Options later
than three months after the date of the Meeting (or such
later date to the extent permitted by any ASX waiver or
modification of the Listing Rules).
Price or other consideration
the Company will receive for
The Shares and Options will be issued at a nil issue price, in
consideration for lead manager servicesprovided byPlutus

12

REQUIRED INFORMATION DETAILS
the Securities Capital under the Placement.
Purpose of the issue,
including the intended use of
any funds raised by the issue
The purpose of the issue is to satisfy the Company’s
obligations under the Lead Manager Mandate.
Summary of material terms of
agreement to issue
The Shares and Options are being issued under the Lead
Manager Mandate, a summary of the material terms of
which is set out in Section 1.2.
Voting exclusion statement A voting exclusion statement applies to this Resolution.

5. RESOLUTION 8 – APPROVAL TO ISSUE OPTIONS TO ANTANAS GUOGA

5.1 Background

The Company has engaged the services of Antanas Guoga to act as a technical advisor to the Company through a strategic advisory agreement dated 18 December 2024 ( Strategic Advisory Agreement ).

Pursuant to the Strategic Advisory Agreement the Company has agreed to issue Antanas Guoga 25,000,000 Options exercisable at $0.10 on or before the date that is 2 years from the date of issue.

The advisory services to be provided by Antanas Guoga under the Strategic Advisory Agreement the include:

  • (a) providing his expertise in the management and investment in digital assets to generate asset growth and returns;

  • (b) introduce the Company to opportunities for digital asset acquisition and investment; and

  • (c) assist the Company with introduction for opportunities for staking and validating transactions on digital asset blockchains.

5.2 General

This Resolution seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of 25,000,000 Options to Antanas Guoga (or his nominee(s)) in consideration for advisory services provided to the Company.

  • 5.3 Listing Rule 7.1

A summary of Listing Rule 7.1 is set out in Section 2.2 above.

The proposed issue falls within exception 17 of Listing Rule 7.2. It therefore requires the approval of Shareholders under Listing Rule 7.1.

5.4 Technical information required by Listing Rule 14.1A

If this Resolution is passed, the Company will be able to proceed with the issue. In addition, the issue will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If this Resolution is not passed, the Company will not be able to proceed with the issue. Accordingly, the Company would have to pay its fees owing to Antanas Guoga for its advisory services in cash which would further deplete the Company’s existing cash reserves.

  • 5.5 Technical information required by Listing Rule 7.3
REQUIRED INFORMATION DETAILS
Names of persons to whom The Options will be issued to Antanas Guoga (or his
Securities will be issued or nominee(s)).

13

REQUIRED INFORMATION DETAILS
the basis on which those
persons were or will be
identified/selected
Number of Securities and
class to be issued
25,000,000 Options will be issued to Antanas Guoga (or his
nominee(s)).
Terms of Securities The Options will be issued on the terms and conditions set
out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Options within 5 Business
Days of the Meeting. In any event, the Company will not
issue any of the Options later than three months after the
date of the Meeting (or such later date to the extent
permitted by any ASX waiver or modification of the Listing
Rules).
Price or other consideration
the Company will receive
for the Securities
The Options will be issued at a nil issue price, in consideration
for advisory services provided by Antanas Guoga to the
Company.
Purpose of the issue,
including the intended use
of any funds raised by the
issue
The purpose of the issue is to satisfy the Company’s
obligations under the Strategic Advisory Agreement.
Summary of material terms
of agreement to issue
The Options are being issued pursuant to the Strategic
Advisory Agreement as outlined in Section 5.1.
Voting exclusion statement A voting exclusion statement applies to this Resolution.

6. RESOLUTION 9 – RATIFICATION OF PRIOR ISSUE OF OPTIONS TO DAVIDE BOSIO

6.1 General

This Resolution seeks Shareholder ratification for the purposes of Listing Rule 7.4 for the issue of 10,000,000 Options to Mr Davide Bosio exercisable at $0.10 each on or before the date that is 5 years from the date of issue.

6.2 Listing Rule 7.1

A summary of Listing Rule 7.1 is set out in Section 2.2 above.

The issue does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has not yet been approved by Shareholders, it effectively uses up part of the 15% limit in Listing Rule 7.1, reducing the Company’s capacity to issue further equity securities without Shareholder approval under Listing Rule 7.1 for the 12 month period following the date of the issue.

6.3 Listing Rule 7.4

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further equity securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional equity securities in the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to Listing Rule 7.4 for the issue.

6.4 Technical information required by Listing Rule 14.1A

If this Resolution is passed, the issue will be excluded in calculating the Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of the issue.

14

If this Resolution is not passed, the issue will be included in calculating the Company’s 15% limit in Listing Rule 7.1, effectively decreasing the number of equity securities that the Company can issue without Shareholder approval over the 12 month period following the date of the issue.

6.5 Technical information required by Listing Rules 7.4 and 7.5

REQUIRED INFORMATION DETAILS
Names of persons to whom
Securities were issued or the
basis on which those
persons were
identified/selected
The Options were issued to Mr Davide Bosio.
Number and class of
Securities issued
10,000,000 Options were issued.
Terms of Securities The Options were issued on the terms and conditions set out
in Schedule 2.
Date(s) on or by which the
Securities were issued
3 December 2024.
Price or other consideration
the Company received for
the Securities
The Options were issued at a nil price per Option.
Purpose of the issue,
including the intended use
of any funds raised by the
issue
No funds were raised from the issue as the Options were
issued at a nil price per Option.
Summary of material terms
of agreement to issue
The Options were issued as part of Mr Bosio’s appointment
as a Director of the Company.
Voting Exclusion Statement A voting exclusion statement applies to this Resolution.
Compliance The issue did not breach Listing Rule 7.1.

7. RESOLUTIONS 10 TO 12 – APPROVAL TO ISSUE OPTIONS TO RELATED PARTIES

7.1 General

These Resolutions seek Shareholder approval for the purposes of Listing Rule 10.11 for the issue of up to an aggregate of 30,000,000 Options to Mr Toby Hicks, Mr Peter Rubinstein and Mr Greg Dooley (or their nominee(s))( Related Parties ) on the terms and conditions set out below.

The Directors fees have not increased since 2019 and the Directors do not presently participate in any of the short term or long term incentive plans in place for the Company’s employees.

QUANTUM RECIPIENT RESOLUTION EXERCISE PRICE
EXPIRY DATE
10,000,000 Toby Hicks 10 $0.10 On or before the date
that is 2 years after the
date of issue.
10,000,000 Peter Rubinstein 11 $0.10 On or before the date
that is 2 years after the
date of issue.
10,000,000 Greg Dooley 12 $0.10 On or before the date
that is 2 years after the
date of issue.

15

7.2 Director Recommendation

Each Director has a material personal interest in the outcome of these Resolutions on the basis that all of the Directors (or their nominee(s)) are to be issued the Options should these Resolutions be passed. For this reason, the Directors do not believe that it is appropriate to make a recommendation on these Resolutions.

7.3 Listing Rule 10.11

Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue equity securities to:

  • 10.11.1 a related party;

  • 10.11.2 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (30%+) holder in the company;

  • 10.11.3 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (10%+) holder in the company and who has nominated a director to the board of the company pursuant to a relevant agreement which gives them a right or expectation to do so;

  • 10.11.4 an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3; or

  • 10.11.5 a person whose relationship with the company or a person referred to in Listing Rules 10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be approved by its shareholders,

unless it obtains the approval of its shareholders.

The issue falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.

7.4 Technical information required by Listing Rule 14.1A

If these Resolutions are passed, the Company will be able to proceed with the issue within one month after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules). As approval pursuant to Listing Rule 7.1 is not required for the issue (because approval is being obtained under Listing Rule 10.11), the issue will not use up any of the Company’s 15% annual placement capacity.

If these Resolutions are not passed, the Company will not be able to proceed with the issue and may be forced to re-negotiate alternative means of remunerating the Related Parties. This could involve increasing the cash remuneration paid to the related which will have the effect of depleting the Company’s cash reserves.

7.5 Technical Information required by Listing Rule 10.13 and section 219 of the Corporations Act in respect of these Resolutions

REQUIRED INFORMATION DETAILS
Name of the persons to
whom Securities will be
issued
The proposed recipients of the Options are Mr Toby Hicks, Mr
Peter Rubinstein and Greg Dooley as set out in Section 4.1
above.
Categorisation under Listing
Rule 10.11
Each of the proposed recipients falls within the category set
out in Listing Rule 10.11.1 as they are a related party of the
Company by virtue of being a Director.
Any nominee(s) of the proposed recipients who receive
Securities may constitute ‘associates’ for the purposes of
Listing Rule 10.11.4.
Number of Securities and
class to be issued
The maximum number of Options to be issued (being the
nature of the financial benefit proposed to be given) is
30,000,000 which will be allocated in the manner set out in
Section 4.1 above.
Terms of Securities The Options will be issued on the terms and conditions set

16

REQUIRED INFORMATION DETAILS
out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Options within 5 Business
Days of the Meeting. In any event, the Company will not
issue any Options later than one month after the date of the
Meeting (or such later date to the extent permitted by any
ASX waiver or modification of the Listing Rules).
Price or other consideration
the Company will receive
for the Securities
The Options will be issued at a nil issue price.
Purpose of the issue,
including the intended use
of any funds raised by the
issue
The purpose of the issue is to provide a performance linked
incentive component in the remuneration package for the
proposed recipients to align the interests of the proposed
recipients with those of Shareholders, to motivate and
reward the performance of the proposed recipients in their
roles as Directors and to provide a cost effective way from
the Company to remunerate the proposed recipients, which
will allow the Company to spend a greater proportion of its
cash reserves on its operations than it would if alternative
cash forms of remuneration were given to the proposed
recipients.
Consideration of type of
Security to be issued
The Company has agreed to issue the Options for the
following reasons:
(a)
the issue of the Options has no immediate
dilutionary impact on Shareholders;
(b)
the deferred taxation benefit which is available to
the Related Parties in respect of the issue of the
Options is also beneficial to the Company as it
means the Related Parties are not required to
immediately sell the Options to fund a tax liability
(as would be the case in an issue of Shares where
the tax liability arises upon issue of the Shares) and
will instead, continue to hold an interest in the
Company;
(c)
the issue is a reasonable and appropriate method
to provide cost effective remuneration as the non-
cash form of this benefit will allow the Company to
spend a greater proportion of its cash reserves on
its operations than it would if alternative cash
forms of remuneration were given to the Related
Parties; and
(d)
it is not considered that there are any significant
opportunity costs to the Company or benefits
foregone by the Company in issuing the Options
on the terms proposed.
Consideration of quantum of
Securities to be issued
The number of Securities to be issued has been determined
based upon a consideration of:
(a)
current market standards and/or practices of
other ASX listed companies of a similar size and
stage of development to the Company;
(b)
the remuneration of the proposed recipients; and
(c)
incentives to attract and ensure continuity of
service of the proposed recipients who have
appropriate knowledge and expertise, while
maintaining the Company’s cash reserves.
The Company does not consider that there are any
significant opportunity costs to the Company or benefits
foregone bythe Companyin issuingthe Securities upon the

17

REQUIRED INFORMATION DETAILS
terms proposed.
Remuneration The total remuneration package for each of the proposed
recipients for the previous financial year and the proposed
total remuneration package for the current financial year
are set out below:
RELATED PARTY
CURRENT
FINANCIAL YEAR
ENDING 30 JUNE
2025
PREVIOUS
FINANCIAL YEAR
ENDED 30 JUNE
2024
Toby Hicks
$75,969
$75,969
Peter Rubinstein
$50,646
$50,646
Greg Dooley
$118,9662
$58,966
Notes:
1.
Comprising
Directors’
fees
and
salary
and
superannuation.
2.
Includes $10,000 per month that Mr Dooley is receiving
as remuneration for acting in his role as the Interim
Chief Executive Officer of the Company following the
resignation of the Company’s Chief Executive Officer in
September 2024.
Valuation The value of the Options and the pricing methodology is set
out in Schedule 3.
Summary of material terms
of agreement to issue
The Options are being issued pursuant to the Related Party’s
agreements with the Company.
Interest in Securities The relevant interests of the proposed recipients in Securities
as at the date of this Notice and following completion of the
issue are set out below:
As at the date of this Notice
RELATED PARTY
SHARES1
UNDILUTED
Toby Hicks
9,002,9653
1.04%
Peter Rubinstein
36,578,3204
4.22%
Greg Dooley
1,773,6012
0.20%
Post issue
RELATED PARTY
SHARES1
OPTIONS
FULLY
DILUTED
Toby Hicks
9,002,9653
10,000,000
2.05%
Peter
Rubinstein
36,578,3204
10,000,000
5.03%
Greg Dooley
1,773,6012
10,000,000
1.27%
Notes:
1.
Fully paid ordinary shares in the capital of the Company (ASX:
DCC).
2.
Held indirectly through Totolola Pty Ltd ATF Belinda & Gregory
D SF of which Mr Greg Dooley is Shareholder and Beneficiary.
3.
Securities held by Emboodhu Pty Ltd ATF the TA and EL Hicks
Family Trust of which Mr Hicks is a Director and beneficiary of
the trust.
4.
Comprising: 617,284 Shares held directly; 17,196,296 Shares
held indirectly through Irwin Biotech Nominees Pty Ltd;
8,487,580
Shares
held
indirectly
through
Irwin
Biotech

18

REQUIRED INFORMATION DETAILS DETAILS DETAILS
Nominees Pty Ltd ATF BIOA Trust; 3,694,444 Shares held
indirectly through RIP Opportunities Pty Ltd ATF PIR Super Fund;
and 7,200,000 Shares held indirectly through ValueAdmin.Com
Pty Ltd.
Dilution If the Options issued under these Resolutions are exercised, a
total of 30,000,000 Shares would be issued. This will increase
the number of Shares on issue from 866,404,031 (being the
total number of Shares on issue as at the date of this Notice)
to 896,404,031 (assuming that no Shares are issued and no
other convertible securities vest or are exercised) with the
effect that the shareholding of existing Shareholders would
be diluted by an aggregate of 3.35%, comprising 1.14% by
Mr Toby Hicks 1.14% by Mr Peter Rubinstein and 1.14% by Mr
Greg Dooley.
Market price The market price for Shares during the term of the Options
would normally determine whether or not the Options are
exercised. If, at any time any of the Options are exercised
and the Shares are trading on ASX at a price that is higher
than the exercise price of the Options, there may be a
perceived cost to the Company.
Trading history The trading history of the Shares on ASX in the 12 months
before the date of this Notice is set out below:
PRICE
DATE
Highest
$0.086
12 March 2024
Lowest
$0.035
4 October 2024
Last
$0.053
13 December 2024
PRICE DATE
Highest
Lowest
Last
$0.086 12 March 2024
$0.035 4 October 2024
$0.053 13 December 2024
Other information The Board is not aware of any other information that is
reasonably required by Shareholders to allow them to
decide whether it is in the best interests of the Company to
pass these Resolutions.
Voting exclusion statements Voting exclusion statements apply to these Resolutions.
Voting prohibition
statements
Voting prohibition statements apply to these Resolutions.

19

G L O S S AR Y

  • $ means Australian dollars.

ASIC means the Australian Securities & Investments Commission.

ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.

Chair means the chair of the Meeting.

Closely Related Party of a member of the Key Management Personnel means:

  • (a) a spouse or child of the member;

  • (b) a child of the member’s spouse;

  • (c) a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

  • (e) a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth) for the purposes of the definition of ‘closely related party’ in the Corporations Act.

Company means DigitalX Limited (ACN 009 575 035).

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the current directors of the Company.

Explanatory Statement means the explanatory statement accompanying the Notice.

Key Management Personnel has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.

Lead Manager Mandate has the meaning given in Section 1.2.

Listing Rules means the Listing Rules of ASX.

Meeting means the meeting convened by the Notice.

Notice means this notice of meeting including the Explanatory Statement and the Proxy Form.

Option means an option to acquire a Share.

Placement has the meaning given in Section 1.

Proxy Form means the proxy form accompanying the Notice.

Related Parties has the meaning given in Section 7.1.

Related Party Participants has the meaning given in Section 1.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.

Section means a section of the Explanatory Statement.

20

Security means a Share, Option, Performance Right or Performance Share (as applicable).

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share. Unrelated Placement Participants has the meaning given in Section 1.

WST means Western Standard Time as observed in Perth, Western Australia.

21

S C H E DU L E 1 – TE R MS A N D C O N D IT I O N S OP T I O N S

(a) Entitlement

Each Option entitles the holder to subscribe for one Share upon exercise of the Option.

(b) Exercise Price

Subject to paragraph (j), the amount payable upon exercise of each Option and will be $0.10 ( Exercise Price ).

(c) Expiry Date

Each Option will expire at 5:00 pm (WST) on the date that is 2 years from the date of issue ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d) Exercise Period

The Options are exercisable at any time on or prior to the Expiry Date ( Exercise Period ).

  • (e) Notice of Exercise

The Options may be exercised during the Exercise Period by notice in writing to the Company in the manner specified on the Option certificate ( Notice of Exercise ) and payment of the Exercise Price for each Option being exercised in Australian currency by electronic funds transfer or other means of payment acceptable to the Company.

(f) Exercise Date

A Notice of Exercise is only effective on and from the later of the date of receipt of the Notice of Exercise and the date of receipt of the payment of the Exercise Price for each Option being exercised in cleared funds ( Exercise Date ).

(g) Timing of issue of Shares on exercise

Within five Business Days after the Exercise Date, the Company will:

  • (i) issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Notice of Exercise and for which cleared funds have been received by the Company;

  • (ii) if required, give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors; and

  • (iii) if admitted to the official list of ASX at the time, apply for official quotation on ASX of Shares issued pursuant to the exercise of the Options.

If a notice delivered under (g)(ii) for any reason is not effective to ensure that an offer for sale of the Shares does not require disclosure to investors, the Company must, no later than 20 Business Days after becoming aware of such notice being ineffective, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors.

(h) Shares issued on exercise

Shares issued on exercise of the Options rank equally with the then issued shares of the Company.

(i) Quotation of Shares issued on exercise

Application will be made by the Company to ASX for quotation of the Shares issued upon exercise of the Options.

  • (j) Reconstruction of capital

22

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(k) Participation in new issues

There are no participation rights or entitlements inherent in the Options and holders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options without exercising the Options.

(l) Change in exercise price

An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Option can be exercised.

(m) Transferability

The Options are transferable subject to any restriction or escrow arrangements imposed by ASX or under applicable Australian securities laws.

23

S C H E DU L E 2 – TE R MS A N D C O N D IT I O N S OP T I O N S

(a) Entitlement

Each Option entitles the holder to subscribe for one Share upon exercise of the Option.

(b) Exercise Price

Subject to paragraph (j), the amount payable upon exercise of each Option and will be $0.10 ( Exercise Price ).

(c) Expiry Date

Each Option will expire at 5:00 pm (WST) on 31 December 2029 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d) Exercise Period

The Options are exercisable at any time on or prior to the Expiry Date ( Exercise Period ).

(e) Notice of Exercise

The Options may be exercised during the Exercise Period by notice in writing to the Company in the manner specified on the Option certificate ( Notice of Exercise ) and payment of the Exercise Price for each Option being exercised in Australian currency by electronic funds transfer or other means of payment acceptable to the Company.

(f) Exercise Date

A Notice of Exercise is only effective on and from the later of the date of receipt of the Notice of Exercise and the date of receipt of the payment of the Exercise Price for each Option being exercised in cleared funds ( Exercise Date ).

(g) Timing of issue of Shares on exercise

Within five Business Days after the Exercise Date, the Company will:

  • (i) issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Notice of Exercise and for which cleared funds have been received by the Company;

  • (ii) if required, give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors; and

  • (iii) if admitted to the official list of ASX at the time, apply for official quotation on ASX of Shares issued pursuant to the exercise of the Options.

If a notice delivered under (g)(g)(ii) for any reason is not effective to ensure that an offer for sale of the Shares does not require disclosure to investors, the Company must, no later than 20 Business Days after becoming aware of such notice being ineffective, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors.

(h) Shares issued on exercise

Shares issued on exercise of the Options rank equally with the then issued shares of the Company.

(i) Quotation of Shares issued on exercise

Application will be made by the Company to ASX for quotation of the Shares issued upon exercise of the Options.

24

(j) Reconstruction of capital

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(k) Participation in new issues

There are no participation rights or entitlements inherent in the Options and holders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options without exercising the Options.

(l) Change in exercise price

An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Option can be exercised.

(m) Transferability

The Options are transferable subject to any restriction or escrow arrangements imposed by ASX or under applicable Australian securities laws.

25

S C H E DU L E 3 – V AL U A T I O N O F O P TI O N S

The Options to be issued pursuant to Resolutions 7 to 12 have been valued by internal management .

Using the Black & Scholes option model and based on the assumptions set out below, the Options were ascribed the following value:

Assumptions:
Valuation date 11 December 2024
Market price of Shares 4.6 cents
Exercise price 10 cents
Expiry date (length of time from issue) 2 years from date of issue
Risk free interest rate 4.35%
Volatility (discount) 88.5%
Indicative value per Option 1.3 cents
Total Value of Options $390,000
- Toby Hicks (Resolution 5) $130,000
- Peter Rubinstein (Resolution 6) $130,000
- Greg Dooley (Resolution 7) $130,000

Note: The valuation noted above is not necessarily the market price that the Options could be traded at and is not automatically the market price for taxation purposes.

26

Proxy Voting Form If you are attending the Meeting in person, please bring this with you for Securityholder registration.

DigitalX Limited | ABN 59 009 575 035

==> picture [236 x 58] intentionally omitted <==

Your proxy voting instruction must be received by 9.30am (AWST) on Wednesday, 29 January 2025 , being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.

SUBMIT YOUR PROXY

SUBMIT YOUR PROXY
Complete the form overleaf in accordance with the instructions set out below.
YOUR NAME AND ADDRESS
The name and address shown above is as it appears on the Company’s share register. If this information is
incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor
portal:https://investor.automic.com.au/#/homeShareholders sponsored by a broker should advise their
broker of any changes.
STEP 1 – APPOINT A PROXY
If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of
that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you
leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.
DEFAULT TO THE CHAIR OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting,
who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the
Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the
Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel.
STEP 2 - VOTES ON ITEMS OF BUSINESS
You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All
your shares will be voted in accordance with such a direction unless you indicate only a portion of voting
rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the
appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may
vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.
APPOINTMENT OF SECOND PROXY
You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy
Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a
percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms
together. If you require an additional Proxy Voting Form, contact Automic Registry Services.
SIGNING INSTRUCTIONS
Individual:Where the holding is in one name, the Shareholder must sign.
Joint holding:Where the holding is in more than one name, all Shareholders should sign.
Power of attorney:If you have not already lodged the power of attorney with the registry, please attach a
certified photocopy of the power of attorney to this Proxy Voting Form when you return it.
Companies:To be signed in accordance with your Constitution. Please sign in the appropriate box which
indicates the office held by you.
Email Address:Please provide your email address in the space provided.
By providing your email address, you elect to receive all communications despatched by the Company
electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual
Report via email.
CORPORATE REPRESENTATIVES
If a representative of the corporation is to attend the Meeting the appropriate ‘Appointment of Corporate
Representative’ should be produced prior to admission. A form may be obtained from the Company’s share
registry online at https://automicgroup.com.au.
Lodging your Proxy Voting Form:
Online
Use your computer or smartphone to
appoint a proxy at
https://investor.automic.com.au/#/loginsahor
scan the QR code below using your
smartphone
Login & Click on ‘Meetings’. Use the
Holder Number as shown at the top of
this Proxy Voting Form.
BY MAIL:
Automic
GPO Box 5193
Sydney NSW 2001
IN PERSON:
Automic
Level 5, 126 Phillip Street
Sydney NSW 2000
BY EMAIL:
[email protected]
BY FACSIMILE:
+61 2 8583 3040
All enquiries to Automic:
WEBSITE:
https://automicgroup.com.au
PHONE:
1300 288 664 (Within Australia)
+61 2 9698 5414 (Overseas)

STEP 1 - How to vote

APPOINT A PROXY:

I/We being a Shareholder entitled to attend and vote at the General Meeting of DigitalX Limited, to be held at 9.30am (AWST) on Friday, 31 January 2025 at Level 14, QV1 Building, 250 St Georges Terrace Perth, Western Australia hereby:

==> picture [37 x 171] intentionally omitted <==

Appoint the Chair of the Meeting (Chair) OR if you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy or failing the person so named or, if no person is named, the Chair, or the Chair’s nominee, to vote in accordance with the following directions, or, if no directions have been given, and subject to the relevant laws as the proxy sees fit and at any adjournment thereof.

The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is entitled to vote. Unless indicated otherwise by ticking the “for”, “against” or “abstain” box you will be authorising the Chair to vote in accordance with the Chair’s voting intention. AUTHORITY FOR CHAIR TO VOTE UNDIRECTED PROXIES ON REMUNERATION RELATED RESOLUTIONS Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair to exercise my/our proxy on Resolutions 3, 4, 5, 10, 11 and 12 (except where I/we have indicated a different voting intention below) even though Resolutions 3, 4, 5, 10, 11 and 12 are connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.

STEP 2 - Your voting direction STEP 2 - Your voting direction
Resolutions
For
Against Abstain
Resolutions
For
Against Abstain
1
RATIFICATION OF PRIOR ISSUE OF SHARES
UNDER PLACEMENT – LISTING RULE 7.1
7
APPROVAL TO ISSUE OPTIONS TO PLUTUS
CAPITAL
2
RATIFICATION OF PRIOR ISSUE OF SHARES
UNDER PLACEMENT – LISTING RULE 7.1A
8
APPROVAL TO ISSUE OPTIONS TO
ANTANAS GUOGA
3
APPROVAL TO ISSUE SHARES TO A
RELATED PARTY – MR PETER RUBINSTEIN
9
RATIFICATION OF PRIOR ISSUE OF
OPTIONS TO MR DAVIDE BOSIO
4
APPROVAL TO ISSUE SHARES TO A
RELATED PARTY – MR GREG DOOLEY
10
APPROVAL TO ISSUE OPTIONS TO A
RELATED PARTY – MR TOBY HICKS
5
APPROVAL TO ISSUE SHARES TO A
RELATED PARTY – DAVIDE BOSIO
11
APPROVAL TO ISSUE OPTIONS TO A
RELATED PARTY – MR PETER RUBINSTEIN
6
APPROVAL TO ISSUE SHARES TO PLUTUS
CAPITAL
12
APPROVAL TO ISSUE OPTIONS TO A
RELATED PARTY – MR GREG DOOLEY
Please note:If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on
a poll and your votes will not be counted in computing the required majority on a poll.

STEP 3 – Signatures and contact details

Individual or Securityholder 1 Individual or Securityholder 1 Individual or Securityholder 1 Individual or Securityholder 1 Individual or Securityholder 1 Individual or Securityholder 1 Securityholder 2 Securityholder 2 Securityholder 2 Securityholder 2 Securityholder 3 Securityholder 3 Securityholder 3 Securityholder 3 Securityholder 3 Securityholder 3 Securityholder 3 Securityholder 3
Sole Director and Sole Company Secretary Director Director / Company Secretary
Contact Name:
Email Address:
Contact Daytime Telephone Date (DD/MM/YY)
/ /
By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible).